Showing results (91-100 of 374) with videos related to
Sort By:
Pageof 38
Diabetes Care|February 24, 2018
Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 DiabetesCharlotte Koopal, Frank L J Visseren, Jan Westerink, et al.European Journal of Preventive Cardiology|July 28, 2017
SPRINT trial: It's not just the blood pressure!Gijs Fn Berkelmans, Frank Lj Visseren, Nicole Em Jaspers, et al.The American Journal of Cardiology|January 3, 2015
Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular diseaseAnton P van de Woestijne, Yolanda van der Graaf, Jan Westerink, et al.Cardiovascular Diabetology|October 18, 2017
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trialsMarit de Jong, H Bart van der Worp, Yolanda van der Graaf, et al.Stroke|July 3, 2010
Cost-effectiveness of magnetic resonance angiography versus intra-arterial digital subtraction angiography to follow-up patients with coiled intracranial aneurysmsJoanna D Schaafsma, Hendrik Koffijberg, Erik Buskens, et al.Journal of Cardiovascular Pharmacology|August 2, 2008
The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trialJobien K Olijhoek, Gideon R Hajer, Yolanda van der Graaf, et al.Plos One|April 27, 2012
Unrequested findings on cardiac computed tomography: looking beyond the heartConstantinus F Buckens, Helena M Verkooijen, Martijn J Gondrie, et al.Cardiovascular Diabetology|November 22, 2011
Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART studySandra N Verhagen, Annemarie M J Wassink, Yolanda van der Graaf, et al.European Journal of Clinical Investigation|February 13, 2013
Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposityDaniël R Faber, Yolanda van der Graaf, Jan Westerink, et al.Diabetes Care|August 17, 2019
Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD TrialTamar I de Vries, Jannick A N Dorresteijn, Yolanda van der Graaf, et al.Pageof 38